FDA Advisory Committee Recommends Novavax COVID-19 Vaccine

On Tuesday, June 7, the FDA's Vaccines and Related Biological Products Advisory Committee voted to recommend that regulators authorize a COVID-19 vaccine made by Novavax.

Before becoming available for use, the Novavax vaccine will require additional approvals from the FDA – which include signing off on its manufacturing processes – as well as from the CDC.